p30T-Ec1
(Plasmid
#260816)
-
PurposeEc1 homolog in p30T; established that it targets multiple phages with different DNA modifications in E. coli
-
Depositing Lab
-
Depositing OrganizationUniversity of California, San Francisco (UCSF)
Located in the United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 260816 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepHERD30T
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Gentamicin, 10 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsGrow at 15µg/ml gentamicin
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameEND(Ec1)
-
SpeciesE .coli
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
p30T-Ec1 was a gift from Joseph Bondy-Denomy (Addgene plasmid # 260816 ; http://n2t.net/addgene:260816 ; RRID:Addgene_260816) -
For your References section:
END nucleases are antiphage defence systems targeting multiple phages with modified genomes. Yee WX, Lee YJ, Makarova KS, Klein TA, Wirganowicz A, Gabagat AE, Liu M, Csorgo B, Koonin EV, Weigele PR, Bondy-Denomy J. Nat Microbiol. 2026 Jun 26. doi: 10.1038/s41564-026-02407-2. 10.1038/s41564-026-02407-2 PubMed 42362811